8-K: Current report
8-K: Current report
8-K: Current report
8-K: Current report
8-K: Cyclacel Pharmaceuticals Reports SECOND quarter financial results and provides business update
S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
8-K: Current report
8-K: Cyclacel Pharmaceuticals Reports first quarter financial results and provides business update
DEFA14A: Others
DEF 14A: Definitive information statements
S-1: General form for registration of securities under the Securities Act of 1933
8-K: Current report
8-K: Current report
S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Cyclacel Pharmaceuticals Inc | 8-K: Current report
Cyclacel Pharmaceuticals Inc | S-1: General form for registration of securities under the Securities Act of 1933
Cyclacel Pharmaceuticals Inc | 8-K: Cyclacel Pharmaceuticals Reports fourth quarter and full year 2023 financial results and provides business update
Cyclacel Pharmaceuticals Inc | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Cyclacel Pharmaceuticals Inc | 8-K: Current report
No Data
No Data